IVF Services Market
in India was valued at $256.0 million
in 2016, and is projected to reach $829.5 million by 2023, registering a CAGR
of 18.2% from 2017 to 2023. Modern lifestyle, increase in infertility rate
among couples, and rise in spending of middle class and higher class for IVF
treatment are the major factors that boost the growth of the market.
In vitro fertilization
(IVF) is an assisted reproductive technology (ART) procedure. It is the process
of fertilization, which includes eggs extraction, sperm cell sample retrieval,
and then manually combining an egg and sperm in laboratory settings to form an
embryo. The embryo(s) is then transferred to the uterus for further gestation.
The India IVF
services market is expected to witness a substantial growth in future owing to
rise in incidence of infertility cases, emerging trend of delayed pregnancies
among women, and increased occurrences of gamete donations. Furthermore, low
cost clinical settings for IVF treatments in India when compared with IVF
treatment facilities in the U.S., the UK, and other established markets, rise
in popularity of medical and fertility tourism coupled with advanced IVF
facilities & treatment options are anticipated to supplement the market
growth.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2172
The prominent
companies, hospitals, surgical centers, fertility centers, and clinical
research institutes profiled in this report include Sun Pharmaceuticals
Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila
Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd.,
Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center,
Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela
Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.)
Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt.
Ltd.).
Other players
(profiles not included in the report) in the value chain analysis include, Apollo
Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.
With respect to end
users, the fertility clinics segment accounted for about 61% of the India IVF
services market revenue in 2016, and is projected to maintain its dominance
during the forecast period. In addition, this segment performed 77.4 thousand
cycles in 2016, and is projected to reach 245.4 thousand by 2023, growing at a
CAGR of 17.9%, thus accounting for the highest number of IVF cycles. This is
attributed to the fact that fertility clinics provide technologically advanced
and a wide range of fertility treatments under a single roof for patients.
Based on cycle
type, the fresh IVF cycles segment (non-donor) generated the highest revenue of
$187.1 million in 2016, and is expected to reach $606.6 million by 2023,
growing at a CAGR of 18.2%. In addition, this segment was the largest segment
in the India IVF services market, with 80.1 thousand fresh IVF cycles
(non-donor) performed in 2016, and is expected to reach 239.6 thousand cycles
by 2023, growing at a CAGR of 16.9% from 2017 to 2023.
Get Discount UP To 25% * Offer Till 31st
Dec 2018@ https://www.alliedmarketresearch.com/checkout/240070
Key Findings of the
India Ivf Services Market:
- Based
on cycle type, in 2016, fresh IVF cycle (non-donor) segment accounted for
around 70% share of the total market, in terms of revenue
- Thawed
IVF cycle (non-donor) is projected to be the one of the fastest growing
segments, registering a CAGR of 19.6% from 2017 to 2023, in terms of
revenue
- Based
on gender, in 2016, the female infertility segment, in terms of volume,
accounted for more than 70% share of the total market.
- Based
on IVF procedures, in 2016, non-ICSI IVF accounted for the highest
revenue, thereby registering a CAGR of 19.2% from 2017 to 2023.
Access Full Summery @ https://www.alliedmarketresearch.com/india-ivf-services-market
No comments:
Post a Comment